Initial results of a phase 1b/2 study of ADG126 (a masked anti-CTLA-4 SAFEbody(r)) in combination with pembrolizumab (an anti-PD-1 antibody) in patients with advanced/metastatic solid tumors
ADG126;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Initial results of a phase 1b/2 study of ADG126 (a masked anti-CTLA-4 SAFEbody(r)) in combination with pembrolizumab (an anti-PD-1 antibody) in patients with advanced/metastatic solid tumors ### Output: ADG126;Pembrolizumab